- Home
- WKEY vs ABOS Comparison
WKEY vs ABOS Comparison
Compare WKEY & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- ABOS
- Stock Information
- Founded
- WKEY 1999
- ABOS 1996
- Country
- WKEY Switzerland
- ABOS United States
- Employees
- WKEY N/A
- ABOS N/A
- Industry
- WKEY EDP Services
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- ABOS Health Care
- Exchange
- WKEY Nasdaq
- ABOS Nasdaq
- Market Cap
- WKEY 112.9M
- ABOS 99.1M
- IPO Year
- WKEY N/A
- ABOS 2021
- Fundamental
- Price
- WKEY $6.90
- ABOS $1.47
- Analyst Decision
- WKEY Strong Buy
- ABOS Strong Buy
- Analyst Count
- WKEY 1
- ABOS 3
- Target Price
- WKEY $4.00
- ABOS $9.33
- AVG Volume (30 Days)
- WKEY 1.3M
- ABOS 306.2K
- Earning Date
- WKEY 09-30-2024
- ABOS 03-25-2025
- Dividend Yield
- WKEY N/A
- ABOS N/A
- EPS Growth
- WKEY N/A
- ABOS N/A
- EPS
- WKEY N/A
- ABOS N/A
- Revenue
- WKEY $20,985,000.00
- ABOS N/A
- Revenue This Year
- WKEY N/A
- ABOS N/A
- Revenue Next Year
- WKEY $81.73
- ABOS N/A
- P/E Ratio
- WKEY N/A
- ABOS N/A
- Revenue Growth
- WKEY N/A
- ABOS N/A
- 52 Week Low
- WKEY $1.61
- ABOS $1.45
- 52 Week High
- WKEY $14.00
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- WKEY 46.30
- ABOS 34.22
- Support Level
- WKEY $6.22
- ABOS $1.56
- Resistance Level
- WKEY $8.06
- ABOS $1.62
- Average True Range (ATR)
- WKEY 1.09
- ABOS 0.12
- MACD
- WKEY -0.30
- ABOS 0.00
- Stochastic Oscillator
- WKEY 15.53
- ABOS 10.51
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.